# New Truncal Nerve Blocks for Thoracoscopic Surgery and Open Heart Surgery.

> **NCT03704753** · PHASE4 · UNKNOWN · sponsor: **Tampere University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT03704753
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-25
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03704753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03704753, "New Truncal Nerve Blocks for Thoracoscopic Surgery and Open Heart Surgery.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03704753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*